Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Praxis Precision Medicines Inc
(NQ:
PRAX
)
51.45
-2.07 (-3.87%)
Streaming Delayed Price
Updated: 1:58 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Praxis Precision Medicines Inc
< Previous
1
2
3
4
5
6
Next >
These Analysts Increase Their Forecasts On Praxis Precision Medicines After Q2 Results
August 14, 2024
Via
Benzinga
PRAX Stock Earnings: Praxis Precision Medicine Beats EPS, Misses Revenue for Q2 2024
August 13, 2024
PRAX stock results show that Praxis Precision Medicine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 13, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024
August 05, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
What 6 Analyst Ratings Have To Say About Praxis Precision Medicine
August 05, 2024
Via
Benzinga
Demystifying Praxis Precision Medicine: Insights From 7 Analyst Reviews
June 18, 2024
Via
Benzinga
Are We Having Fun Yet? Stocks Sell Off On Massive Volume
August 03, 2024
In this video, I review the overall market, my game-plan with the indices, how our largest swings are holding up, and the stocks on my radar.
Via
Talk Markets
Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails
July 24, 2024
The companies are no longer developing their drug for essential tremor treatment.
Via
Investor's Business Daily
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
July 09, 2024
Via
Benzinga
Quarterly & Long-Term Portfolios For The Win
July 06, 2024
What a day for Meta! I was planning to add to my position, but the volume was too low. I would have been shaken out of most of it for the swing before it could become this position trade.
Via
Talk Markets
Value Of Praxis Precision Medicines' Lead Program In Essential Tremor Alone Is Underappreciated: Analyst
June 24, 2024
Needham rates Praxis Precision Medicines Buy with a $145 target. Key programs include ulixacaltamide for essential tremor (Phase 3 results expected in 2024) and PRAX-628 for focal seizures.
Via
Benzinga
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
June 20, 2024
The companies are working on treatments for essential tremor, a tricky indication.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 20, 2024
Via
Benzinga
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
May 31, 2024
Via
Benzinga
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
May 17, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Critical Insights From Praxis Precision Medicine Analyst Ratings: What You Need To Know
May 16, 2024
Via
Benzinga
PRAX Stock Earnings: Praxis Precision Medicine Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
PRAX stock results show that Praxis Precision Medicine missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 13, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
May 10, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
April 12, 2024
Innovative design of ongoing Phase 3 clinical program expected to set precedent for future clinical trials in essential tremor
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Participate in Upcoming April Conferences
April 05, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
March 28, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
March 27, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...
Via
Benzinga
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday
March 26, 2024
Praxis Precision Medicines updates Phase 2a study on PRAX-628 in epilepsy patients with photo paroxysmal response, indicating positive response and safety profile, advancing plans for focal epilepsy...
Via
Benzinga
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
March 26, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Praxis, A Top 1% Stock, Soars To Year-High After Epilepsy Treatment Scores Big
March 26, 2024
The company said 100% of patients who received the high dose responded to its drug.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.